Rockefeller Capital Management L.P. Zymeworks Inc. Transaction History

Rockefeller Capital Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$4.65 - $7.43 $6,449 - $10,305	-1,387 Reduced 48.04%	1,500 $9,000
Q1 2022 May 13, 2022	BUY	$6.0 - $16.98 $9,000 - $25,470	1,500 Added 108.15%	2,887 $18,000
Q4 2020 Feb 12, 2021	SELL	$39.12 - $54.99 $19,599 - $27,549	-501 Reduced 26.54%	1,387 $65,000
Q1 2020 May 12, 2020	BUY	$24.28 - $49.8 $7,891 - $16,184	325 Added 20.79%	1,888 $67,000
Q4 2019 Feb 07, 2020	SELL	$24.84 - $45.46 $48,115 - $88,056	-1,937 Reduced 55.34%	1,563 $71,000
Q3 2019 Nov 12, 2019	BUY	$22.78 - $29.08 $79,730 - $101,780	3,500 New	3,500 $87,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.